Skip to main content
Premium Trial:

Request an Annual Quote

Quark Closes $10M Private Financing Round


Quark Pharmaceuticals said this week that it has closed a $10 million round of private financing.

The company said it will use the funds to advance its RNAi drug pipeline, which includes the phase I acute renal failure treatment QPI 1002, which is also under phase I/II development for the prevention of delayed graft function; and QPI 1007, a phase I ocular neuroprotectant.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more